Follow the Brooks Laboratories Limited share price and the full directors' dealings record of the company, a publicly traded company based in India. Shares are listed on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Brooks Laboratories Limited has published 9 insider filings. Market capitalisation: €1.8bn. The latest transaction was reported on 15 November 2024 (Sale). Among the most active insiders: Atul Ranchal. All data is openly available.
9
Insider Decl.
n/a
Thresholds
€235,830
5 ops.
Buy Volume
€2m
4 ops.
Sell Volume
10Σ signal
Buys €235,830€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,580 of 29,063 companies
78.4
score / 100
Value
77
Quality
80
FCF yld3.2%
Earn yld14%
EV/EBITDA7.0x
ROE22%
Gross mgn40%
Net mgn29%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.